Oncology & Cancer

RNA regulator of melanoma could be a new target for cancer therapy

Melanoma is the most deadly form of skin cancer, estimated by the National Cancer Institute to afflict more than 70,000 people in the United States annually and the incidence rate continues to rise. In a study published online ...

Genetics

Eye color may indicate risk for serious skin conditions

Eye color may be an indicator of whether a person is high-risk for certain serious skin conditions. A study, led by the University of Colorado School of Medicine, shows people with blue eyes are less likely to have vitiligo. ...

Oncology & Cancer

Even young teens show signs of sun damage: study

(HealthDay) -- In a new study that used a special type of photography to unveil hidden signs of sun damage, middle schoolers showed evidence of levels of UV exposure that could raise their risk for melanoma later in life.

Oncology & Cancer

Study finds dramatic rise in skin cancer in young adults

Even as the rates of some cancers are falling, Mayo Clinic is seeing an alarming trend: the dramatic rise of skin cancer, especially among people under 40. According to a study by Mayo Clinic researchers published in the ...

Oncology & Cancer

Study reveals trigger that may speed melanoma growth

(HealthDay) -- Growth of the deadly skin cancer melanoma may be triggered by the immune system turning on itself, according to a new study that also identified the mechanism that causes this to happen.

Oncology & Cancer

Researchers building melanoma vaccine to combat skin cancer

Mayo Clinic researchers have trained mouse immune systems to eradicate skin cancer from within, using a genetic combination of human DNA from melanoma cells and a cousin of the rabies virus. The strategy, called cancer immunotherapy, ...

Oncology & Cancer

Dose-Response link between tanning bed use, skin cancer

(HealthDay) -- Use of tanning beds, especially in high school and college, is associated with an increased risk of skin cancer, according to a study published online Feb. 27 in the Journal of Clinical Oncology.

page 28 from 39